查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1886299

透皮貼片市場－全球產業規模、佔有率、趨勢、機會和預測，按貼片類型、黏合劑類型、應用、最終用戶、地區和競爭格局分類，2020-2030年預測

Transdermal Patches Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Patch Type, By Adhesive Type, By Application, By End-User, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球透皮貼片市場規模為68.5億美元，預計2030年將以5.03%的複合年成長率成長至92億美元。透皮貼片是一種藥物黏附系統，旨在透過皮膚進行全身給藥，繞過肝臟首過代謝，提供非侵入性且穩定的治療劑量。市場成長的主要促進因素是全球慢性病盛行率的不斷上升，這些疾病需要長期用藥管理，以及患者明顯傾向於選擇便捷、非侵入性的給藥方式，而非傳統的口服或注射途徑。

市場概覽
預測期 2026-2030
市場規模：2024年 68.5億美元
市場規模：2030年 92億美元
複合年成長率：2025-2030年 5.03%
成長最快的細分市場 醫院和診所
最大的市場 北美洲

主要市場促進因素

全球慢性疾病負擔日益加重，成為推動透皮貼片市場發展的關鍵因素，尤其對於需要持續、長期用藥的疾病更是如此。透皮貼片系統具有顯著優勢，能夠實現藥物的持續釋放，與傳統的口服或注射給藥途徑相比，可提高患者的依從性和治療的穩定性。

主要市場挑戰

皮膚滲透性的固有限制嚴重阻礙了全球透皮貼片市場的成長。這種生理屏障從根本上限制了可透過皮膚途徑有效遞送的活性藥物成分的分子大小和理化性質。

主要市場趨勢

微針技術的進步從根本上拓展了透皮給藥的途徑，它能夠突破皮膚屏障，從而實現更廣泛的治療藥物（包括大分子藥物）的給藥。這些貼片在角質層中形成微小通道，以最小的侵入性和更少的不適感實現藥物的高效滲透，從而拓寬了透皮給藥的應用範圍。

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球透皮貼片市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依貼片類型（藥物黏合劑貼片、基質貼片、儲庫膜貼片、微針貼片、蒸氣貼片）
    • 依黏合劑類型（丙烯酸、矽膠、水凝膠、其他）
    • 依應用領域（疼痛管理、荷爾蒙應用、中樞神經系統疾病、心血管疾病、戒菸、其他）
    • 按最終使用者（家庭護理機構、醫院和診所）
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美透皮貼片市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲透皮貼片市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區透皮貼片市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲透皮貼片市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美透皮貼片市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章：全球透皮貼片市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • AbbVie, Inc.
  • AdhexPharma SAS
  • Agile Therapeutics, Inc.
  • Boehringer Ingelheim International GmbH
  • Corium, Inc.
  • GlaxoSmithKline PLC
  • Johnson & Johnson Services, Inc.
  • Novartis AG
  • Hamamatsu Pharma Research, Inc.
  • Endo, Inc.

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 23930

The Global Transdermal Patches Market, valued at USD 6.85 Billion in 2024, is projected to experience a CAGR of 5.03% to reach USD 9.20 Billion by 2030. Transdermal patches represent medicated adhesive systems designed for systemic drug delivery through the skin, offering a non-invasive and consistent therapeutic dosage by bypassing hepatic first-pass metabolism. The market's growth is principally driven by the increasing global prevalence of chronic diseases requiring long-term medication management and a discernible patient preference for convenient, non-invasive drug administration over traditional oral or injectable routes.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 6.85 Billion
Market Size 2030USD 9.20 Billion
CAGR 2025-20305.03%
Fastest Growing SegmentHospitals & Clinics
Largest MarketNorth America

Key Market Drivers

The escalating global burden of chronic diseases stands as a pivotal driver for the transdermal patches market, particularly for conditions necessitating continuous and often long-term medication management. Transdermal systems offer distinct advantages by enabling sustained drug release, which enhances patient adherence and therapeutic consistency over conventional oral or injectable routes. This non-invasive administration lessens the discomfort associated with frequent dosing and potential systemic side effects, improving the quality of life for individuals with persistent health issues.

Key Market Challenges

The inherent limitation of skin permeability poses a significant impediment to the growth of the Global Transdermal Patches Market. This physiological barrier fundamentally restricts the molecular size and physicochemical properties of active pharmaceutical ingredients that can be effectively delivered through the dermal route. Consequently, the range of drug candidates suitable for transdermal formulation is substantially narrowed, limiting the expansion of transdermal patches into numerous therapeutic areas. Large molecule biologics, for example, which represent a growing segment of pharmaceutical innovation, are generally incompatible with transdermal delivery due to their size.

Key Market Trends

Advancements in microneedle technology are fundamentally expanding transdermal drug delivery by overcoming the skin's barrier, enabling the administration of a wider range of therapeutic agents, including larger molecules. These patches create microscopic channels in the stratum corneum for efficient drug permeation with minimal invasiveness and reduced discomfort, broadening transdermal applications.

Key Market Players

  • AbbVie, Inc.
  • AdhexPharma SAS
  • Agile Therapeutics, Inc.
  • Boehringer Ingelheim International GmbH
  • Corium, Inc.
  • GlaxoSmithKline PLC
  • Johnson & Johnson Services, Inc.
  • Novartis AG
  • Hamamatsu Pharma Research, Inc.
  • Endo, Inc.

Report Scope:

In this report, the Global Transdermal Patches Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Transdermal Patches Market, By Patch Type:

  • Drug-In-Adhesive
  • Matrix Patches
  • Reservoir Membrane Patches
  • Microneedle Patches
  • Vapour Patches

Transdermal Patches Market, By Adhesive Type:

  • Acrylic
  • Silicone
  • Hydrogel
  • Other

Transdermal Patches Market, By Application:

  • Pain Management
  • Hormonal Application
  • Central Nervous System Disorders
  • Cardiovascular Diseases
  • Smoking Cessation
  • Other

Transdermal Patches Market, By End-User:

  • Homecare Settings
  • Hospitals & Clinics

Transdermal Patches Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Transdermal Patches Market.

Available Customizations:

Global Transdermal Patches Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Transdermal Patches Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Patch Type (Drug-In-Adhesive, Matrix Patches, Reservoir Membrane Patches, Microneedle Patches, Vapour Patches)
    • 5.2.2. By Adhesive Type (Acrylic, Silicone, Hydrogel, Other)
    • 5.2.3. By Application (Pain Management, Hormonal Application, Central Nervous System Disorders, Cardiovascular Diseases, Smoking Cessation, Other)
    • 5.2.4. By End-User (Homecare Settings, Hospitals & Clinics)
    • 5.2.5. By Region
    • 5.2.6. By Company (2024)
  • 5.3. Market Map

6. North America Transdermal Patches Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Patch Type
    • 6.2.2. By Adhesive Type
    • 6.2.3. By Application
    • 6.2.4. By End-User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Transdermal Patches Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Patch Type
        • 6.3.1.2.2. By Adhesive Type
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End-User
    • 6.3.2. Canada Transdermal Patches Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Patch Type
        • 6.3.2.2.2. By Adhesive Type
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End-User
    • 6.3.3. Mexico Transdermal Patches Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Patch Type
        • 6.3.3.2.2. By Adhesive Type
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End-User

7. Europe Transdermal Patches Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Patch Type
    • 7.2.2. By Adhesive Type
    • 7.2.3. By Application
    • 7.2.4. By End-User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Transdermal Patches Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Patch Type
        • 7.3.1.2.2. By Adhesive Type
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End-User
    • 7.3.2. France Transdermal Patches Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Patch Type
        • 7.3.2.2.2. By Adhesive Type
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End-User
    • 7.3.3. United Kingdom Transdermal Patches Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Patch Type
        • 7.3.3.2.2. By Adhesive Type
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End-User
    • 7.3.4. Italy Transdermal Patches Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Patch Type
        • 7.3.4.2.2. By Adhesive Type
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End-User
    • 7.3.5. Spain Transdermal Patches Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Patch Type
        • 7.3.5.2.2. By Adhesive Type
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End-User

8. Asia Pacific Transdermal Patches Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Patch Type
    • 8.2.2. By Adhesive Type
    • 8.2.3. By Application
    • 8.2.4. By End-User
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Transdermal Patches Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Patch Type
        • 8.3.1.2.2. By Adhesive Type
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End-User
    • 8.3.2. India Transdermal Patches Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Patch Type
        • 8.3.2.2.2. By Adhesive Type
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End-User
    • 8.3.3. Japan Transdermal Patches Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Patch Type
        • 8.3.3.2.2. By Adhesive Type
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End-User
    • 8.3.4. South Korea Transdermal Patches Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Patch Type
        • 8.3.4.2.2. By Adhesive Type
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End-User
    • 8.3.5. Australia Transdermal Patches Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Patch Type
        • 8.3.5.2.2. By Adhesive Type
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End-User

9. Middle East & Africa Transdermal Patches Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Patch Type
    • 9.2.2. By Adhesive Type
    • 9.2.3. By Application
    • 9.2.4. By End-User
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Transdermal Patches Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Patch Type
        • 9.3.1.2.2. By Adhesive Type
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End-User
    • 9.3.2. UAE Transdermal Patches Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Patch Type
        • 9.3.2.2.2. By Adhesive Type
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End-User
    • 9.3.3. South Africa Transdermal Patches Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Patch Type
        • 9.3.3.2.2. By Adhesive Type
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End-User

10. South America Transdermal Patches Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Patch Type
    • 10.2.2. By Adhesive Type
    • 10.2.3. By Application
    • 10.2.4. By End-User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Transdermal Patches Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Patch Type
        • 10.3.1.2.2. By Adhesive Type
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End-User
    • 10.3.2. Colombia Transdermal Patches Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Patch Type
        • 10.3.2.2.2. By Adhesive Type
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End-User
    • 10.3.3. Argentina Transdermal Patches Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Patch Type
        • 10.3.3.2.2. By Adhesive Type
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End-User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Transdermal Patches Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. AbbVie, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. AdhexPharma SAS
  • 15.3. Agile Therapeutics, Inc.
  • 15.4. Boehringer Ingelheim International GmbH
  • 15.5. Corium, Inc.
  • 15.6. GlaxoSmithKline PLC
  • 15.7. Johnson & Johnson Services, Inc.
  • 15.8. Novartis AG
  • 15.9. Hamamatsu Pharma Research, Inc.
  • 15.10. Endo, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer